JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCabe, R. T.
Right arrow Articles by Wamsley, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCabe, R. T.
Right arrow Articles by Wamsley, J. K.

Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies

RT McCabe, RW Olsen, JP Yezuita and JK Wamsley

Department of Psychiatry, University of Utah School of Medicine, Salt Lake City.

Inasmuch as the presence of endogenous gamma-aminobutyric acid (GABA) may affect benzodiazepine binding to tissue sections in autoradiographic studies, a protocol designed to check for this influence has been investigated. [3H]Flunitrazepam (1 nM) was used to label benzodiazepine receptors for autoradiographic localization. Bicuculline was added to the incubation medium of an additional set of tissue sections to antagonize any potential effect of endogenous GABA. Binding in these sections was compared to that occurring in another set in which excess GABA was added to "create" further GABA enhancement. Binding also was compared to adjacent sections which were treated similarly but also preincubated in distilled-deionized water to burst the cells by osmotic shock and eliminate endogenous GABA, thereby preventing any effect on benzodiazepine binding. The results indicated that endogenous GABA is indeed present in the slide-mounted tissue sections and is affecting benzodiazepine receptor binding differentially in various regions of the brain depending on the density of GABAergic innervation. Scatchard analysis of saturation data demonstrated that the alteration in benzodiazepine binding due to GABA was a result of a change in the affinity rather than number of receptors present. These experiments have been compared to the binding of the imidazodiazepine, [3H] Ro15-1788. We also show that the treatments affect endogenous GABA and not the receptors themselves. This suggests strongly that, when using a single nonsaturating concentration of radiolabeled benzodiazepine antagonist, autoradiographic studies to date may have been subject to erroneous interpretation due to the differential effects of endogenous GABA on benzodiazepine binding (increased affinity).(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 245, Issue 1, pp. 342-349, 04/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. A. Walsh, M. Li, T.-J. Zhao, T. H. Chiu, and H. C. Rosenberg
Acute Pentylenetetrazol Injection Reduces Rat GABAA Receptor mRNA Levels and GABA Stimulation of Benzodiazepine Binding with No Effect on Benzodiazepine Binding Site Density
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1626 - 1633.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.